Abbott Settles Suits Over Norvir Amid Calls For Compulsory License
Abbott Laboratories has settled two lawsuits over the pricing of Norvir, the anti-HIV drug targeted for a compulsory license by activists and patient groups....To view the full article, register now.
Already a subscriber? Click here to view full article